Profil News

Our expert

Dr. Lars Bochmann

Executive Director Marketing & Business Development

August 12, 2022

The Profil Science Report 2021 - "What Science Can Do"

The Corona pandemic has shown the importance of scientific evidence when it comes to building trust in newly developed drugs given to millions of people. It has also highlighted the importance of

July 19, 2022

Don't let clinical trial subject recruitment hold you back!

The path for the development of new drugs and medicinal products can have many roadblocks ahead. These difficulties, especially at the beginning of developing a new drug, can have drastic

June 27, 2022

Interactive Workshop: "Clinical Trials for Digital Health"

Join our interactive workshop „Clinical Trials for Digital Health: Embracing the New Reality“ which we hold in cooperation with the Innovation in Health and EIT Health Germany-Switzerland GoTo Market

June 14, 2022

Pharmacological options for weight management and people with T2D

The global distribution of health impacts caused by obesity and type 2 diabetes (T2D) in the population has reinforced interest in pharmacological options for weight management [1]. More than 80% of

May 24, 2022

Free Online Seminar: Artificial Intelligence - what is the hype about?

We are happy to announce that our successful series of scientific online seminars continues. On June 21st, 2022 at 4 PM CEST we will air our next complimentary online seminar. The session is

May 17, 2022

New glucose clamp quality parameter: absolute control deviation

Introduction: In glucose clamp experiments, variable glucose infusion rates (GIR) are used to control blood glucose concentration (BG, the ‘physiological variable’) and keep it close to a fixed

April 25, 2022

The German Digital Healthcare Act and DiGA: what is in it for diabetes? (Part III)

Part III: Room for enhancement and learnings from European neighbours The launch of the German fast track pathway for digital health technologies – DiGA [1] - has been met with lots of excitement. It

April 4, 2022

The German Digital Healthcare Act and DiGA: what is in it for diabetes? (Part II)

Part II: Challenges to a wider usage of DiGAs The fast-track pathway for digital health technologies, DiGA, has been introduced in Germany in 2019. It is considered an innovative initiative, as it

March 14, 2022

The German Digital Healthcare Act and DiGA: what is in it for diabetes? (Part I)

Part I: Reimbursement of Digital Health Applications (DiGA) in Germany: an overview In this blog post series of three, we give an overview of the current prescription and reimbursement of DiGAs (Part